Literature DB >> 33651637

Pulmonary Histopathology Findings in Patients With STAT3 Gain of Function Syndrome.

Nahir Cortes-Santiago1, Lisa Forbes2, Tiphanie P Vogel3, Manuel Silva-Carmona3, John Hicks2, R Paul Guillerman4, Akaluck Thatayatikom5, Kalyani Patel6.   

Abstract

INTRODUCTION AND AIM: Multiorgan autoimmunity and interstitial lung disease (ILD) are reported in patients with STAT3 GOF syndrome.
RESULTS: We present lung histopathology findings in 3 such children, two of whom underwent wedge biopsies with adequate diagnostic material. Wedge biopsies showed interstitial cellular expansion with linear and nodular aggregates of CD8 positive T lymphocytes, plasma cells, and histiocytes; consistent with lymphocytic interstitial pneumonia pattern (LIP). CD4+ T cells and CD20+ B cells were present but infrequent in the interstitium. FOXP3 cells ranged from 0-5%. Focal interstitial and intraalveolar histiocytes were also seen. Neutrophils and eosinophils were rare/absent. Non-occlusive peribronchial lymphoid aggregates showed equal T and B cells; likely reactive in nature. Pulmonary vessels appeared normal without vasculitis or hypertensive change. There was no interstitial or subepithelial fibrosis or organizing pneumonia. Interlobular septa and visceral pleura were unremarkable.
CONCLUSION: Children with multi-system autoimmune disorders with ILD should be investigated for STAT3 GOF syndrome. Lung wedge biopsies are more informative than transbronchial biopsies, if a tissue sampling is indicated. CD8 dominant T cell inflammation seems to be a key driver of ILD. Although interstitial fibrosis was not seen in our small sample, longer follow up is needed to understand the natural history.

Entities:  

Keywords:  STAT3; autoimmunity; interstitial lung disease; lung; lymphocytic interstitial pneumonia; pediatric

Year:  2021        PMID: 33651637     DOI: 10.1177/1093526620980615

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  1 in total

1.  A Novel STAT3 Gain-of-Function Mutation in Fatal Infancy-Onset Interstitial Lung Disease.

Authors:  Mengyue Deng; Yue Li; Yulu Li; Xiaolan Mao; Han Ke; Weiling Liang; Xiaoguang Lei; Yu-Lung Lau; Huawei Mao
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.